FDA Clearance Tracker · P970043
LADARVISION EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 2, 1998 (this decision)Source: openFDAMethods & limitations
Decided
Nov 2, 1998
Approval withdrawn
Time to decision
423 days
Received Sep 5, 1997. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P970043
- Device name
- LADARVISION EXCIMER LASER SYSTEM
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Sep 5, 1997
- Decided
- Nov 2, 1998
- Decision
- Approval withdrawn
- Supplements
- 23 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Indicated for use in photorefractive keratectomy (PRK) treatment for the reduction or elimination of mild to moderate myopia in patients with the following three characteristics: 1) between -1.00D to -10.00D of sphere and less than or equal to -4.00D of astigmatism at the spectacle plane, the combination of which must result in an attempted correction between -0.50D and -10.00D spherical equivalent (SE) at the spectacle plane where sphere or cylinder is at least 1.00D; 2) who are 21 years of age or older; and 3) with documented stability of refraction for the prior 12 months, as demonstrated by a change of less than or equal to 0.50D for corrections up to -7.00D SE, and less than or equal to -1.00D for corrections greater than -7.00 D SE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LZS. The earliest in FDA's data is P910067, decided Mar 10, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.